{{Rsnum
|rsid=17852153
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Orientation=plus
|Orientation=plus
|Chromosome=11
|position=69648142
|Gene=CCND1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=CCND1,LOC100996515
|Status=Merged
|Merged=9344
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 30.4 | 41.1 | 28.6
| HCB | 33.6 | 45.3 | 21.2
| JPT | 17.7 | 54.9 | 27.4
| YRI | 3.4 | 28.6 | 68.0
| ASW | 3.5 | 42.1 | 54.4
| CHB | 33.6 | 45.3 | 21.2
| CHD | 37.6 | 42.2 | 20.2
| GIH | 35.6 | 40.6 | 23.8
| LWK | 1.8 | 39.1 | 59.1
| MEX | 19.0 | 37.9 | 43.1
| MKK | 2.6 | 38.5 | 59.0
| TSI | 26.5 | 50.0 | 23.5
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs17852153
|Name_s=CCND1:870G>A
|Gene_s=CCND1
|Feature=Intron
|Evidence=PubMed ID:16788380; PubMed ID:18061885
|Annotation=Colorectal cancer patients treated with cetuximab and carrying the G allele of the Cyclin D1 CCND1:870G>A had longer overall survival than homozygotes of the A allele.
|Drugs=cetuximab
|Drug Classes=
|Diseases=Colorectal Neoplasms
|Curation Level=Curated
|PharmGKB Accession ID=PA162411236
}}{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17852153
|overall_frequency_n=43
|overall_frequency_d=128
|overall_frequency=0.335938
|n_genomes=25
|n_genomes_annotated=0
|n_haplomes=32
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}